Response to A. Chauhan and A. Pal

Br J Cancer. 2022 Jun;126(11):1661-1662. doi: 10.1038/s41416-022-01803-9. Epub 2022 Apr 4.

Authors

Alexios Matikas^{1

2}, Vassilis Georgoulias^{3

4}

Affiliations

¹ Department of Oncology-Pathology, Karolinska Institutet Stockholm, Stockholm, Sweden. alexios.matikas@ki.se.
² Breast Center, Theme Cancer, Karolinska University Hospital, Stockholm, Sweden. alexios.matikas@ki.se.
³ Laboratory of Tumor Cell Biology, University of Crete, Heraklion, Greece.
⁴ Hellenic Oncology Research Group, Athens, Greece.

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms*
Chemotherapy, Adjuvant
Female
Humans
Neoplastic Cells, Circulating*
Prognosis